Alligator Bioscience AB (publ)

SSE:ATORX.ST

1.18 (SEK) • At close February 20, 2024
Bedrijfsnaam Alligator Bioscience AB (publ)
Symbool ATORX.ST
Munteenheid SEK
Prijs 1.178
Beurswaarde 775,069,812
Dividendpercentage 0%
52-weken bereik 0.34 - 1.568
Industrie Biotechnology
Sector Healthcare
CEO Mr. Søren Bregenholt Ph.D.
Website https://www.alligatorbioscience.se

An error occurred while fetching data.

Over Alligator Bioscience AB (publ)

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based drugs for cancer treatment in Sweden. It develops products using its technology platforms, including ALLIGATOR-GOLD and ALLIGATOR-FAB, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and

Vergelijkbare Aandelen

Kancera AB (publ) logo

Kancera AB (publ)

KAN.ST

4.095 SEK

Guard Therapeutics International AB (publ) logo

Guard Therapeutics International AB (publ)

GUARD.ST

19.8 SEK

Initiator Pharma A/S logo

Initiator Pharma A/S

INIT.ST

8.08 SEK

OssDsign AB (publ) logo

OssDsign AB (publ)

OSSD.ST

8.8 SEK

I-Tech AB logo

I-Tech AB

ITECH.ST

39.7 SEK

Ortivus AB (publ) logo

Ortivus AB (publ)

ORTI-B.ST

3.44 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)